China's NMPA approves Eli Lilly's oral GLP-1 orforglipron for adults with obesity. Discover what this first-in-class ...
Addex spinout Neurosterix closes a USD 105M Series B to advance NTX-253 into Phase II. Read the full story on this ...
Eureka Therapeutics will pay JW Therapeutics $10M upfront and up to $100M in milestones for GPC3 and AFP TCR-T rights in ...
Protagenic (PTIX) raises $1.5M in a private placement to advance PT00114 into a U.S. anxiety trial after its Phytanix ...
Flagship Pioneering and Gates Foundation launch a $25M global health unit to fund health and agriculture solutions for ...
See how ImvivaBio's CTA313 CD19/BCMA allogeneic CAR-T sustained responses in refractory lupus, including nephritis, as it ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results